ReportWire

Tag: Mayo Clinic

  • Jury awards Iowa woman $19.8 million for

    [ad_1]

    A jury has awarded an Iowa woman a $19.8 million verdict against Mayo Clinic and a colorectal surgeon in a lawsuit brought in Minnesota courts, according to her attorneys.

    The Iowa-based Hixson & Brown Law Firm represented patient Linette Nelson, of Fort Dodge, Iowa. They alleged in a June 2018 procedure — the second in a series of three surgeries — the surgeon was supposed to move her entire rectum, but “botched a multi-stage operation” and “left 5-7 cm of diseased rectum inside her body.”

    The suit alleged the surgeon dismissed a CT scan that showed “a long rectal cuff” remained inside Nelson and “pushed ahead with the third surgery anyway,” according to attorneys.

    A month later, Nelson was informed by Mayo the surgeon “is gone and we’re not sure if she’ll be back,” according to the law firm. The chief of colorectal surgery for Mayo then examined her and determined the surgeries needed to be redone, a process that took more than a year to complete.

    The firm said negligence by the first surgeon, who now works in California, “left [Nelson] with permanent disfigurement, pelvic floor disorder, fibromyalgia, PTSD, and lifelong chronic pain.”

    Court records show the verdict includes $3.7 million for pain and emotional distress, with another $12.1 million for her future emotional distress. The law firm said the monetary award for Nelson, a mother of two, “is expected to exceed $27 million” when adding in interest.

    “The jury’s verdict speaks truth and justice: world-class reputations don’t excuse life-altering medical negligence,” said attorney LaMar Jost. “This verdict is a step toward accountability for a wife and mother who will suffer for the rest of her life because of medical negligence.”

    A Mayo Clinic spokesperson gave this statement to WCCO on Wednesday morning: “Mayo Clinic respects the jury’s time and the judicial process but is disappointed in the verdict. The organization will evaluate next steps while remaining steadfast in its commitment to providing the highest standards of care and patient outcomes.”

    U.S. News and World Report recently named Mayo Clinic as one of the best hospitals in the country, and also named it best hospital for diabetes, endocrinology, gastroenterology and GI surgery.

    [ad_2]

    Stephen Swanson

    Source link

  • New Mexico boy receives life-changing heart transplant

    [ad_1]

    Hunter Rael, an 8-year-old boy from New Mexico, has received a new heart after experiencing Kawasaki disease, a rare illness that causes inflammation of the blood vessels and serious heart issues.Hunter’s family received a life-changing phone call on Tuesday, informing them that a new heart was available for him. “We were in shock. We were a mix of emotions. We were crying,” Anna Moya, his mother, said.The news comes right around Hunter’s three-year anniversary of his Kawasaki disease diagnosis. On Nov. 1, 2022, Hunter was diagnosed with the rare illness. It primarily affects young children and causes inflammation of blood vessels throughout the body, but in Hunter’s case, it caused serious heart issues.According to the Mayo Clinic, Kawasaki disease most often affects the heart arteries in children. Kids with the illness sometimes have a high fever, swollen hands and feet with skin peeling, red eyes, and tongue. The Mayo Clinic reports that with early treatment, most children get better and have no long-lasting symptoms. On Tuesday, Hunter just got back to New Mexico after traveling to Colorado for a checkup at Children’s Hospital Colorado. Around 11 that morning, he received a phone call he’s been waiting for. “You need to come back. We found Hunter a heart, and it’s go time,” said Moya. He and his mom immediately got on a plane and headed to Colorado.At 5 a.m. Wednesday, Hunter underwent surgery. Cell phone video shared by his family shows the 8-year-old being wheeled back to surgery as he listens to his favorite artist, Jelly Roll. Hunter said Jelly Roll’s music helps keep him calm and gets him through tough times.In October, Hunter got a surprise package from Jelly Roll’s team. It included some gifts and a signed album. According to Hunter, meeting the artist would be a dream come true.Doctors found a bleed flooding the transplant, but were able to fix it. Hunter’s family says right now, Hunter is in stable condition after having a rough night.As of Thursday, Hunter was on an ECMO machine to allow his heart and lungs to rest and heal. His family told sister station KOAT that things are looking good, but it’s going to take some time to see how his body adjusts to the new heart.”They’re slowly starting to kind of wake him up off the sedation. He’ll probably be on that for a few more days. Then we’ll probably have more like of an understanding, make sure everything’s going good, no brain damage, because he’s had a hard hit,” said Moya. “It’s really affecting his body. He’s kind of swollen right now, and they’re trying just to get everything under control.”Hunter and his family want to thank everyone who’s reached out and has been following his journey. “We appreciate all the prayers. Just keep rooting for him. Just keep praying,” said Moya. ‘”As soon as I’m able to show you guys his beautiful face and he’s awake, I will, I will do that … we’ll get him singing Jelly Roll again and we’re going to get there. It’s just going to take time.”

    Hunter Rael, an 8-year-old boy from New Mexico, has received a new heart after experiencing Kawasaki disease, a rare illness that causes inflammation of the blood vessels and serious heart issues.

    Hunter’s family received a life-changing phone call on Tuesday, informing them that a new heart was available for him.

    “We were in shock. We were a mix of emotions. We were crying,” Anna Moya, his mother, said.

    The news comes right around Hunter’s three-year anniversary of his Kawasaki disease diagnosis. On Nov. 1, 2022, Hunter was diagnosed with the rare illness. It primarily affects young children and causes inflammation of blood vessels throughout the body, but in Hunter’s case, it caused serious heart issues.

    According to the Mayo Clinic, Kawasaki disease most often affects the heart arteries in children. Kids with the illness sometimes have a high fever, swollen hands and feet with skin peeling, red eyes, and tongue. The Mayo Clinic reports that with early treatment, most children get better and have no long-lasting symptoms.

    On Tuesday, Hunter just got back to New Mexico after traveling to Colorado for a checkup at Children’s Hospital Colorado. Around 11 that morning, he received a phone call he’s been waiting for.

    “You need to come back. We found Hunter a heart, and it’s go time,” said Moya.

    He and his mom immediately got on a plane and headed to Colorado.

    At 5 a.m. Wednesday, Hunter underwent surgery. Cell phone video shared by his family shows the 8-year-old being wheeled back to surgery as he listens to his favorite artist, Jelly Roll. Hunter said Jelly Roll’s music helps keep him calm and gets him through tough times.

    In October, Hunter got a surprise package from Jelly Roll’s team. It included some gifts and a signed album. According to Hunter, meeting the artist would be a dream come true.

    Doctors found a bleed flooding the transplant, but were able to fix it. Hunter’s family says right now, Hunter is in stable condition after having a rough night.

    As of Thursday, Hunter was on an ECMO machine to allow his heart and lungs to rest and heal. His family told sister station KOAT that things are looking good, but it’s going to take some time to see how his body adjusts to the new heart.

    “They’re slowly starting to kind of wake him up off the sedation. He’ll probably be on that for a few more days. Then we’ll probably have more like of an understanding, make sure everything’s going good, no brain damage, because he’s had a hard hit,” said Moya. “It’s really affecting his body. He’s kind of swollen right now, and they’re trying just to get everything under control.”

    Hunter and his family want to thank everyone who’s reached out and has been following his journey.

    “We appreciate all the prayers. Just keep rooting for him. Just keep praying,” said Moya. ‘”As soon as I’m able to show you guys his beautiful face and he’s awake, I will, I will do that … we’ll get him singing Jelly Roll again and we’re going to get there. It’s just going to take time.”

    [ad_2]

    Source link

  • Gym owner fights to recover after “extremely scary” stroke at 36: “I didn’t know if I’d ever see again”

    [ad_1]

    Donald “Frue” McAvoy and his fiancée, Rachel Leaptrott, were taking it easy on a Sunday in early December 2023, making a cheese board and turning on a football game.

    After one bite, McAvoy began to choke. He couldn’t swallow or breathe. 

    Leaptrott leapt into action. She cleared his throat, but realized that McAvoy’s pupils were locked in place. He was talking, but couldn’t see anything. Leaptrott’s daughter called 911.  

    “It’s like trying to remember a dream. That’s the best way I can describe it,” McAvoy said. “I remember bits and pieces. I get chills, because I couldn’t see and that was extremely scary. But the scariest thing I ever felt, I didn’t know if I’d ever see again.” 

    McAvoy, 36, had recently been plagued by headaches, a sore neck and exhaustion. The active gym owner thought he had a strained neck and might be getting the flu.

    Paramedics said McAvoy was having a neurological issue. Doctors at the Mayo Clinic in Jacksonville, Florida, made a terrifying diagnosis: He was having a severe stroke. 

    Frue McAvoy, Rachel Leaptrott and her daughter before his stroke.

    Frue McAvoy


    A “life-changing” stroke 

    Time is of the essence when treating a stroke. McAvoy was given a clot-busting medication and rushed into surgery.

    Dr. Rabih Tawk, a Mayo Clinic neurosurgeon, performed a thrombectomy to remove the clot and found McAvoy had a vertebral artery dissection that caused the stroke and stopped blood flow to his brain and spine. His airway had collapsed, causing the choking. Strokes in someone as young as McAvoy are unusual, but not impossible, Tawk said. 

    McAvoy came through surgery, but doctors wouldn’t know the extent of the stroke’s effects until he woke up. Tawk said an assessment indicated it would be “life-changing.” 

    “They did scans of his brain, and they described the MRI as ‘fireworks,’” Leaptrott said. “When you do a scan like that, it shows up as a big white spot and a big hit in one area, whereas for Frue, it was like spurts and different areas were hit. It looked like a fire burst through the scan. I only saw that scan once, and it was enough.”  

    img-0088.jpg

    Frue McAvoy in the hospital.

    Frue McAvoy


    For seven days, McAvoy was on a ventilator. It was replaced with breathing and feeding tubes that let him begin therapy. Assessments found that all of his motor skills had been impacted. He would need to relearn how to stand, walk, write and speak. He couldn’t see clearly.

    Through it all, Leaptrott had just one wish: A hug on Christmas Day. 

    “I’ve got to do this”

    Leaptrott’s request gave McAvoy a goal to focus on. He kept it in mind amid therapy, “prodding and pulling” and complications, including two pulmonary embolisms. At first, it took the support of two people just to help him balance in bed, but he pushed himself to relearn how to stand, walk and raise his arms. 

    “I just remember whatever they asked of me, I knew I had to do it to move on to the next thing,” McAvoy said. “I was hooked up to every wire you can think of, but you just trust that all those wires and everything they’re doing is going to lead you to better health.” 

    On Christmas Eve, more than three weeks after the stroke, Leaptrott got her wish.

    screenshot-2025-10-29-at-9-57-44-am.png

    Frue McAvoy and Rachel Leaptrott holding hands in the early days after his stroke.

    Frue McAvoy


    “I just said, ‘OK, I’ve got to do this. If this is the last thing I ever do, I’m going to give it to her,’” McAvoy remembered. 

    After 24 days at the Mayo Clinic, McAvoy was transferred to Brooks Rehabilitation Hospital. When he arrived, he couldn’t stand for more than 10 seconds.

    He was enrolled in “Brooks Boot Camp,” which meant working with therapists, nurses and doctors for at least three hours a day in an individualized program, said physical therapist Stephanie Cabret. He started with goals like increasing his stamina and dressing himself, and eventually progressed to more difficult tasks like preparing food, said occupational therapist Shantal WrightHe also underwent vocal therapy and saw an eye specialist. 

    McAvoy said he focused on staying positive. He asked for extra therapy time whenever possible. He also shared his story online: An Instagram account previously dedicated to fitness became a progress log. Hundreds followed his journey, and McAvoy was able to connect with stroke survivors from around the country.

    “It’s a family I never knew I had or expected to have at this age,” McAvoy said. “It’s just amazing to see how far we’ve all come and are still going.” 

    dsc-0685.jpg

    Frue McAvoy completes a walk at Brooks Rehabilitation. 

    Frue McAvoy


    “Incredibly, incredibly grateful”

    McAvoy was discharged from Brooks Rehabilitation in late January. He could walk down a 200-foot hallway alone. He then had three months of outpatient care. 

    Nearly two years later, McAvoy still struggles with the stroke’s impact. He uses a walker with a seat so he can rest if he gets tired, and he wears glasses now. He struggles with depth perception and can’t drive. But he is back to the activities he loved, including athletics: Four months after the stroke, he took part in a one-mile challenge run. Hours before speaking with CBS News, he and Leaptrott walked the Swinging Mile at Grandfather Mountain, the highest suspension footbridge in the country. 

    screenshot-2025-11-05-at-9-41-20-am.png

    Rachel Leaptrott, Frue McAvoy and Leaptrott’s daughter.

    Frue McAvoy


    McAvoy regularly visits Brooks Rehabilitation’s Neuro Recovery Center, where therapists developed a program he can do on his own. The program adjusts as he does, so he constantly has new milestones to strive for. He is also still in touch with his care team and maintains his social media presence. 

    “With everything going on, I never thought I would hear myself speak again. When you’re in that quiet for so long, you really start thinking about life and what matters and what doesn’t,” McAvoy said. “If I get upset about something or frustrated or angry, I remind myself there was a point in time I couldn’t even express that. I’m just incredibly, incredibly grateful for how my journey has gone.”

    [ad_2]

    Source link

  • Local coffee truck banned from Scottsdale hospital due to name

    [ad_1]

    Audio By Carbonatix

    [ad_2]

    Tirion Boan

    Source link

  • Twin Cities teen discharged from Mayo Clinic with new heart after 246-day-long stay

    [ad_1]

    A Blaine, Minnesota, boy is home after 246 days in the hospital with a new heart thanks to a donor.

    “Getting a heart is not an easy journey, I’d say. And it’s not a quick journey,” Konner Repp said.

    In January, WCCO told you about Konner and his brother, who were both born with heart defects. The Spring Lake Park High School junior was born with hypoplastic right heart, a rare syndrome where part of the heart doesn’t form completely. It led to three open-heart and over seven heart catheterization surgeries.

    “I don’t even know where to start,” said Jennifer Repp, his mother.

    After a recent decline, the 16-year-old went into the hospital on Jan. 6, 202,5 ultimately needing a new one. But with months and weeks of waiting for a match, June 24 brought a ray of hope.

    After 246 days in the hospital, 16-year-old Konner Repp was allowed to go home.

    Jennifer Repp


    “We are blessed beyond belief that Konner has a beautiful new heart beating thanks to a beautiful donor,” said Jennifer Repp.

    Konner Repp was discharged from Mayo Clinic in Rochester, coming home to the sights and sounds of a community that supported him all along.

    “They were all fighting with me during the whole thing,” Konner Repp said.

    Soon, he will get back to being the high schooler he is, after a good night’s sleep, of course.

    An online fundraiser for Konner Repp has raised over $26,000. His mom says it’s still a long road ahead. 

    No information on the heart donor has been provided.

    [ad_2]

    Frankie McLister

    Source link

  • Mattress Mack Back Home After Brief Stay In Hospital

    Mattress Mack Back Home After Brief Stay In Hospital

    [ad_1]

    In true “Mattress Mack” fashion, Jim McIngvale announced he would return to work on Tuesday morning after spending Labor Day weekend in the hospital.

    The Gallery Furniture founder and Houston-area philanthropist arrived home after a three-day stay at St. Luke’s Hospital, where he was diagnosed with a severe case of cellulitis. McIngvale updated his customers regularly about his health condition via posts on X throughout his stay.

    McIngvale told his followers after experiencing nausea on Friday and a loss of cognitive abilities the following day, such as not taking his exit to work properly and confusion about what day it was. He was subsequently rushed to the hospital in a Mobile Stroke Unit on Saturday.

    McIngvale has a history of having ministrokes. So, he said he assumed he was having one again. Instead, healthcare professionals found that the bacterial infection caused McIngvale’s symptoms.

    While sitting in his hospital bed, McIngvale maintained his larger-than-life salesman persona, encouraging his followers to take advantage of his stores’ sales and purchase furniture over the long weekend.

    “The best therapy for me is all these customers buying furniture at Gallery Furniture today,” McIngvale said.

    He also thanked his store patrons for reaching out to him and shared his cell phone number for those wanting to wish him well.

    According to the Mayo Clinic, cellulitis can be common; however, it is potentially serious if it is left untreated. Bacteria enters a break in the skin, usually in the lower legs — but it can also occur on the face, arms and other areas of the body.

    The affected skin is swollen, inflamed, and can be warm or painful to touch. The infection usually remains superficial to the skin, but if the case of cellulitis worsens, it can enter a person’s lymph nodes and bloodstream. Severe cases can lead to toxic shock syndrome, sepsis and other life-threatening complications. It can recur after being treated.

    This story will be updated as needed.

    [ad_2]

    Faith Bugenhagen

    Source link

  • Mayo Clinic destaca los avances en la investigación durante el 2023

    Mayo Clinic destaca los avances en la investigación durante el 2023

    [ad_1]

    Newswise — ROCHESTER, Minnesota — Los investigadores de Mayo Clinic hacen nuevos descubrimientos, desarrollan tecnologías y herramientas únicas en su clase y mejoran constantemente aquellas existentes para brindar el mejor servicio de atención médica. En las 10 historias a continuación se resumen algunos de los avances más importantes en la investigación médica que sucedieron en Mayo Clinic durante el último año. Los descubrimientos incluyen desde aprovechar la inteligencia artificial (IA) para detectar enfermedades de forma temprana hasta lograr avances en tratamientos para enfermedades raras y complejas.

    Los tumores no solo están formados por células cancerosas, sino también por una matriz de pequeños vasos sanguíneos o microvasos que no pueden verse en las imágenes producidas por los ecógrafos convencionales. Para resolver este problema, la Dra. Azra Alizad, médica y científica, y el Dr. Mostafa Fatemi, científico de ingeniería biomédica, se unieron en Mayo Clinic para diseñar y estudiar una herramienta que podría mejorar la resolución de las imágenes por ecografía. Como demuestran los hallazgos de la investigación, desarrollaron un software de imágenes por ecografía de alta resolución, compatible con muchos ecógrafos, que podría mejorar exponencialmente los detalles y la calidad de las imágenes.

    “Si podemos visualizar y captar los microvasos en las etapas más tempranas del cáncer, podemos diagnosticarlo y tratarlo antes, lo que mejora el resultado para el paciente”, afirma la Dra. Alizad, quien se especializa en tecnología de ecografía para la obtención de imágenes de cáncer. Obtener más información.

    Los investigadores de Mayo Clinic se encuentran en el proceso de biofabricación de una vacuna experimental a base de células contra el cáncer de ovario y la combinan con inmunoterapia para estudiar un método de “doble golpe” con el fin de detener el avance de la enfermedad en las pacientes con cáncer de ovario. Esta investigación comienza con una extracción de sangre de mujeres con cáncer de ovario avanzado cuyos tumores reaparecieron después de una cirugía estándar y quimioterapia. Se extraen los glóbulos blancos de la sangre, se convierten en células dendríticas mediante biofabricación y se devuelven a las pacientes. Las células dendríticas actúan como defensores que marchan por el cuerpo y activan el sistema inmunitario para que reconozca y combata el cáncer.

    “Nos estamos basando en un ensayo clínico de fase 1 anterior que mostró resultados prometedores en términos de supervivencia tras la vacuna basada en células dendríticas”, afirma el Dr. Matthew Block, coinvestigador principal y oncólogo médico. “De las 18 pacientes evaluables en el estudio de fase 1, en 11 reapareció el cáncer, pero 7 de ellas (40 por ciento) vivieron sin cáncer por casi 10 años. Por lo general, se espera que en el 90 por ciento de las pacientes con esta afección el cáncer reaparezca”. Obtener más información.

    Los investigadores de Mayo Clinic desarrollaron un nuevo tipo de tratamiento con linfocitos T con receptor quimérico para el antígeno (tratamiento con linfocitos T-CAR) destinado a destruir los tipos de cáncer de células B que reaparecieron y ya no responden al tratamiento. Esta tecnología pionera, diseñada y desarrollada en el laboratorio del Dr. Hong Qin, eliminó tumores de células B cultivados en el laboratorio y tumores implantados en ratones modelo. Los hallazgos preclínicos se publicaron en la revista Cancer Immunology, Immunotherapy.

    “Este estudio demuestra que nuestro tratamiento experimental con linfocitos T-CAR ataca varios tipos de cáncer de sangre, específicamente la leucemia linfocítica crónica”, afirma el Dr. Qin. “Actualmente hay seis tratamientos diferentes con linfocitos T-CAR aprobados para el tratamiento de tipos de cáncer de sangre con recaída. Si bien los resultados son sorprendentes, no todas las personas responden a este tratamiento. Nuestro objetivo es ofrecer tratamientos con linfocitos novedosos adaptados a las necesidades individuales de cada paciente”. Obtener más información.

    La colonoscopia sigue siendo el procedimiento por excelencia para detectar y prevenir el cáncer colorrectal. Pero el procedimiento tiene sus limitaciones. Algunos estudios sugieren que más de la mitad de los casos de cáncer de colon detectados por una colonoscopia surgen de lesiones que no se vieron en las colonoscopias anteriores a las que se sometió el paciente.

    “La IA, en particular el subconjunto de IA llamado visión artificial, se adapta naturalmente a lo que hacemos a través del endoscopio”, explica el Dr. Michael B. Wallace, quien se autodescribe como un cerebrito de la tecnología.

    En el 2022, el Dr. Wallace publicó los resultados de un estudio multicéntrico internacional donde se analizó el impacto de la incorporación de la IA a las colonoscopías de rutina. Su equipo, que incluyó al Dr. James East, un gastroenterólogo de Mayo Clinic Healthcare en Londres, y a investigadores de EE. UU., el Reino Unido, Italia, Alemania e Irlanda, determinó que la incorporación de la IA en las colonoscopías redujo el riesgo de pasar por alto pólipos un 50 por ciento. Obtener más información.

    Unos meses después de que la paciente de Mayo Clinic de 9 años Maggie Carmichael comenzara a tomar el medicamento experimental para su enfermedad genética ultrarrara que es parte de una categoría de enfermedades conocida como trastornos congénitos de la glucosilación, la pequeña pudo cambiar su silla de ruedas por un andador. La médica que trata a Maggie es la Dra. Eva Morava-Kozicz, una científica traslacional de Mayo Clinic que se encuentra al frente de la investigación de trastornos congénitos de la glucosilación. 

    En un descubrimiento reciente, la Dra. Morava-Kozicz y sus colaboradores determinaron que una de las principales causas de los trastornos congénitos de la glucosilación es la acumulación de una sustancia llamada sorbitol, que es un tipo de alcohol de azúcar que se produce en el cuerpo cuando se metaboliza la glucosa. La Dra. Morava-Kozicz afirma que el descubrimiento del sorbitol abrió la puerta a un biomarcador para diagnosticar la enfermedad y determinar la gravedad de la enfermedad. Explica que el avance del biomarcador proporcionó una estrategia que permite implementar posibles medicamentos candidatos. Obtener más información.

    Los médicos y los investigadores del mundo están combinando la inteligencia artificial, conocida como IA, con la atención médica para identificar a los pacientes con un mayor riesgo de presentar enfermedades cardiovasculares, como accidentes cerebrovasculares e insuficiencia cardíaca. Sin embargo, a medida que aumenta el uso de estas herramientas mejoradas con IA, los investigadores en Mayo Clinic se preguntan: “¿Estas herramientas funcionan de forma fiable en las personas de color?” y “¿son accesibles en los entornos de atención médica comunitaria?”.

    “Con frecuencia se desarrollan y utilizan intervenciones de salud basadas en IA sin analizar ni validar datos específicos de la raza”, afirma el Dr. David Harmon, médico “fellow” de cardiología en Mayo Clinic. “Es importante asegurarse de que estas herramientas sean confiables y accesibles para todas las personas, en particular aquellas de color que se ven afectadas de forma desproporcionada por las enfermedades cardiovasculares”. Obtener más información.

    Los investigadores de Mayo Clinic identificaron un amplio rango de sustancias químicas ambientales en la bilis humana de pacientes con colangitis esclerosante primaria, una enfermedad hepática crónica y poco común que afecta los conductos biliares. El estudio, que se publicó en Exposome, representa una nueva frontera de investigación en el Centro de Medicina Personalizada en Mayo Clinic que explora el exposoma, la medida en que el ambiente contribuye a las enfermedades y la salud. Para el estudio, los investigadores observaron muestras de bilis de pacientes con la enfermedad por medio de una espectrometría de masas de alta resolución y encontraron diversas sustancias químicas ambientales. Esta nueva tecnología permitió que los investigadores midieran y analizaran las exposiciones a sustancias químicas externas y sus respuestas biológicas, con la suficiente cobertura para estudiar las relaciones entre posibles iniciadores de enfermedades y sus efectos.

    “Los descubrimientos sobre las relaciones de sustancias químicas y metabolómicas en la bilis sirven como punto de partida”, dice el investigador de Mayo Clinic Dr. Konstantinos N. Lazaridis, el director ejecutivo a cargo de Carlson y Nelson para el Centro de Medicina Personalizada en Mayo Clinic. “Son esenciales para comprender los cambios bioquímicos que ocurren debido a la exposición a sustancias químicas ambientales, ya que pueden reflejar la causa y progresión de la colangitis esclerosante primaria y pueden llevar a nuevos tratamientos médicos”. Obtener más información.

    Los investigadores del Centro Oncológico Integral de Mayo Clinic descubren evidencia que respalda un menor período de tratamiento para pacientes con cáncer de mama en un ensayo aleatorizado, publicado en la revista The Lancet Oncology. El estudio comparó dos cronogramas de administración de dosis distintos de la terapia de protones con haz concentrado, el tipo más avanzado de terapia de protones conocido por su precisión a la hora de dirigirse a las células cancerosas, al tiempo que preserva el tejido sano para reducir el riesgo de que se produzcan efectos secundarios.

    “El estudio proporciona los primeros datos prospectivos que respaldan el uso de la radioterapia de protones después de una mastectomía con protones de ciclo más breve, incluso en pacientes con reconstrucción mamaria inmediata, y los primeros resultados consolidados de un ensayo aleatorizado en el campo de la radioterapia de mama con partículas”, afirma el Dr. Robert Mutter, oncólogo radioterapeuta y médico científico del Centro Oncológico Integral de Mayo Clinic. “Ahora podemos considerar la opción de 15 días de terapia con pacientes en función de resultados similares del tratamiento observados en el ciclo convencional más largo. Cabe destacar que el ciclo breve en realidad redujo los efectos secundarios en la piel durante y después del tratamiento”. Obtener más información.

    Con un procedimiento de diagnóstico llamado electromiografía, los científicos de Mayo Clinic y sus colaboradores internacionales usaron electrodos para registrar la respuesta eléctrica de los músculos durante cada movimiento. Las pruebas demostraron que un área profunda del surco central estaba activa durante todos los tipos de movimiento, lo que cuestionaba la creencia arraigada de que el tejido de esta parte del cerebro está coordinado con regiones específicas del cuerpo.

    “Esperábamos encontrar el mapa conocido de la organización corporal hasta las profundidades del cerebro, pero nos sorprendió encontrar también esta área que está activa durante todos los diferentes movimientos”, relata el Dr. Kai Miller, neurocirujano de Mayo Clinic y autor principal del estudio. “Las tácticas emergentes para estimular el cerebro con el fin de tratar trastornos del movimiento, como el temblor, podrían aprovechar este hallazgo para obtener mejor respuesta terapéutica”. Obtener más información

    Los síntomas relacionados con la menopausia, como sofocos, sudoración nocturna, cambios en el estado de ánimo, alteraciones del sueño, dolores en las articulaciones y dificultades cognitivas, perjudican la calidad de vida de millones de mujeres. También pueden afectar negativamente a las mujeres en el lugar de trabajo. Un estudio de Mayo Clinic cuantifica ese costo: un total aproximado de $1800 millones en horas de trabajo perdidas y $26 600 millones si se agregan los gastos médicos, solo en Estados Unidos.  “La conclusión para los empleadores es que existe una necesidad fundamental de abordar este problema para las mujeres en el lugar de trabajo”, afirma la Dra. Stephanie Faubion, autora principal y directora de Salud de la Mujer de Mayo ClinicObtener más información.

    ###

    Información sobre Mayo Clinic

    Mayo Clinic es una organización sin fines de lucro, dedicada a innovar la práctica clínica, la educación y la investigación, así como a ofrecer pericia, compasión y respuestas a todos los que necesitan recobrar la salud. Visite la Red Informativa de Mayo Clinic para leer más noticias sobre Mayo Clinic.

    [ad_2]

    Mayo Clinic

    Source link

  • La explicación científica detrás de algunas reacciones extrañas del cuerpo

    La explicación científica detrás de algunas reacciones extrañas del cuerpo

    [ad_1]

    Newswise — EAU CLAIRE, Wisconsin — A diario, el cuerpo hace algunas cosas bastante extrañas e inusuales. A continuación, se incluyen algunas preguntas y respuestas que ofrecen la explicación científica de por qué suceden.

    ¿Por qué se arrugan los dedos de las manos en el agua?

    Inicialmente, se pensaba que los dedos se arrugaban en el agua por los cambios en los líquidos que ocurren entre los tejidos y el agua en la que están inmersos. Expertos en evolución hallaron evidencia de que esto puede haber permitido a los seres humanos a agarrar mejor los objetos bajo el agua. A las personas con lesiones nerviosas en los dedos de las manos o de los pies generalmente no se les arrugan los dedos de la misma forma.

    ¿Por qué a veces siento un pulso en los oídos?

    El pulso en los oídos puede deberse a diversos motivos. El tinnitus suele describirse como un timbre en los oídos, pero existe una variación en la que la persona siente y escucha el pulso en los oídos. Esto se denomina tinnitus pulsátil. Un aumento en la presión arterial o una obstrucción en el conducto auditivo puede ocasionar que la persona escuche el pulso. Otra causa puede ser una anomalía en las arterias próximas a los oídos. Este es un motivo para consultar con su equipo de atención médica.

    ¿Por qué tiritamos cuando hace frío?

    Tiritar cuando hace frío es una manera de hacer temblar a los músculos para generar calor. El cuerpo siempre intenta mantener la temperatura lo más cercana posible a 98,6 grados (37 °C).

    ¿Por qué algunas personas estornudan cuando miran el sol?

    Esto se conoce como reflejo del estornudo fótico. La explicación teórica detrás de esta reacción es la siguiente: el nervio óptico, que detecta un cambio en la luz, está ubicado cerca del nervio trigémino, que controla los estornudos. Un estornudo típico se produce por una irritación en la nariz, que activa al nervio trigémino y desencadena un estornudo. Al salir de una habitación a oscuras hacia un lugar con iluminación brillante, las pupilas se contraen. Este reflejo rápido se inicia en el nervio óptico y puede dar la sensación de irritación en la nariz, lo que genera el estornudo. No todas las personas tienen esta reacción, y no está claro por qué algunas la tienen y otras no.

    ¿Por qué siento una punzada en el costado al correr?

    Las punzadas en el costado se ocasionan por la irritación del diafragma, un músculo que separa la cavidad pulmonar y la cavidad abdominal. Los corredores novatos o quienes incrementan el ritmo o la distancia tienen más probabilidades de sentir punzadas en el costado. En ocasiones, la causa es una respiración demasiado rápida o una alimentación inapropiada antes de correr. Si siente una punzada en el costado, disminuya la velocidad, estire los músculos del torso y concéntrese en respirar lenta y regularmente.

    ¿Por qué el párpado comienza a contraerse de repente?

    La contracción del párpado se llama blefaroespasmo. Se desconoce la causa exacta, pero se suele atribuir a la fatiga, al consumo de cafeína y al estrés. Se recomienda estirar el músculo que se está contrayendo halándolo suavemente con la punta de los dedos en el área y descansar bien. En general, la contracción desaparece sola. Si la contracción dura más de un par de días o tiene dificultad para abrir el párpado, será necesario que lo vea un profesional de atención médica.

    — Amy Rantala, M.D., atiende pacientes en Ortopedia y Medicina Deportiva en Eau Claire, Wisconsin.

    ### 

    Información sobre Mayo Clinic
    Mayo Clinic es una organización sin fines de lucro, dedicada a innovar la práctica clínica, la educación y la investigación, así como a ofrecer pericia, compasión y respuestas a todos los que necesitan recobrar la salud. Visite la Red Informativa de Mayo Clinic para leer más noticias sobre Mayo Clinic.

    [ad_2]

    Mayo Clinic

    Source link

  • فهم العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) وآثارها الجانبية المحتملة

    فهم العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) وآثارها الجانبية المحتملة

    [ad_1]

    جاكسونفيل، فلوريدا — العلاج المناعي يسخر جهاز المناعة في الجسم لمحاربة السرطان. العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (العلاج بخلايا CAR-T) هو شكل من أشكال العلاج المناعي الذي يقوم فيه أخصائيو الرعاية الصحية بإزالة الخلايا التائية للشخص — خلايا الدم البيضاء المعروفة باسم الخلايا اللمفية التي تشارك في استجابة الجهاز المناعي — وتعديلها وراثيًا لإنتاج مستقبلات المستضد الخيمرية (CARs). يتم بعد ذلك حقن الخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) مرة أخرى في مجرى دم المريض، حيث تستهدف الخلايا السرطانية وتقتلها.

    يقول دكتور محمد خرفان دباجة، دكتور في الطب اختصاصي الدَّمَويات والأورام في مايو كلينك: “يعد العلاج بخلايا CAR-T من بين أكثر المجالات الواعدة لعلاج السرطان، مع العديد من قصص النجاح في جميع أنحاء العالم. لقد أعطى أملًا جديدًا للمرضى الذين كانت لديهم في السابق خيارات محدودة.”

    من مؤهل للعلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T)؟

    وافقت إدارة الأدوية الفيدرالية على العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) لعلاج سرطانات الدم التالية:

    الأشخاص الذين يعانون من هذه التشخيصات والذين لم يستجب مرضهم للعلاج (المقاومة) أو الذين انتكس مرضهم قد يكونون مؤهلين للعلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T). يجب أن يخضع المرضى لتقييم شامل لتحديد ما إذا كان العلاج بخلايا CAR-T هو الخيار الأفضل للعلاج.

    كم يستغرق الأمر من الوقت لإتمام العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T)؟

    تعتبر عملية العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) معقدة ويمكن أن تستغرق عدة أسابيع. يعاني معظم الأشخاص من رد فعل تجاه الخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) مما قد يتطلب منهم البقاء في المستشفى للمراقبة والإدارة.

    يقول الدكتور خرفان دباجة: “يجب على الأشخاص الذين يخططون لتلقي العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) أن يتوقعوا البقاء في المستشفى بعد حقن الخلايا لعدة أيام حتى يتمكن فريق الرعاية الخاص بهم من مراقبة استجابتهم للعلاج”.

    ما الآثار الجانبية المحتملة للعلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T)؟

    في حين أن الآثار الجانبية لعلاج الخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) قابلة للعكس بشكل عام، إلا أن الدكتور خرفان دباجة يقول إنها قد تشمل:

    • متلازمة إطلاق السيتوكين (CRS): تعد متلازمة إطلاق السيتوكين (CRS) أحد الآثار الجانبية الأكثر شيوعًا للعلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T)، وتنجم عن الاستجابة المناعية التي تحدث عند إدخال الخلايا التائية المعدلة إلى مجرى دم المريض. عندما تبدأ الخلايا التائية في استهداف الخلايا السرطانية، فإنها تطلق عددًا كبيرًا من السيتوكينات – وهي بروتينات يمكن أن تتسبب في المبالغة في رد فعل الجهاز المناعي. وقد يؤدي هذا إلى الحُمّى، وانخفاض ضغط الدم، وآلام في العضلات وأعراض أخرى تشبه أعراض الإنفلونزا. في الحالات الشديدة، يمكن أن نسبب متلازمة إطلاق السيتوكين (CRS) فشل الأعضاء وحتى أن تكون مميتة. يمكن التحكم في معظم الأعراض المرتبطة بمتلازمة إطلاق السيتوكين (CRS) باستخدام الأدوية والمراقبة الحثيثة.
    • السمية العصبية: قد يعاني بعض المرضى من تأثير عصبي يعرف باسم السمية العصبية بعد تلقي العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T). هذه حالة خطيرة محتملة تؤثر فيها الاستجابة المناعية للعلاج على الجهاز العصبي المركزي. في حين أن السبب الدقيق للتسمم العصبي غير مفهومًا جيدًا، تشير بعض الدراسات إلى أنه يرتبط جزئيًا بخطورة متلازمة إطلاق السيتوكين (CRS). يمكن أن تشمل الأعراض الارتباك والنوبات المَرَضية وصعوبة التحدث أو المشي. يتم حل معظم حالات السمية العصبية من خلال المراقبة الحثيثة دون آثار جانبية طويلة المدى.
    • اضطرابات الدم: يمكن أن يؤدي العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) إلى تغيرات في الدم يمكن أن تؤدي إلى فقر الدم ، ونقص الصفيحات (انخفاض عدد الصفائح الدموية) واضطرابات الدم الأخرى. عادةً ما تكون هذه التأثيرات قصيرة الأمد وتختفي من تلقاء نفسها بمرور الوقت، ولكنها قد تكون أكثر خطورة لدى بعض المرضى.
    • العَدوى: قد يكون الأشخاص الذين يتلقون العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) أكثر عرضة للإصابة بالعدوى، خاصة خلال الأسابيع القليلة الأولى بعد العلاج عندما يعمل الجهاز المناعي وقتًا إضافيًا لمحاربة السرطان. يمكن أن يبقى الأشخاص الذين يعانون من انخفاض عدد خلايا الدم البيضاء أكثر عرضة لخطر الإصابة بالعَدوى لبعض الوقت. ويجب مراقبتهم عن قرب بحثًا عن مؤشرات العَدوى، بما في ذلك الحُمّى والقشعريرة والشعور العام بالتوعك.
    • الآثار الجانبية طويلة المدى: نظرًا لأن العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) لا يزال جديدًا نسبيًا، فإن المتخصصين في الرعاية الصحية لا يعلمون بعد النطاق الكامل لآثاره الجانبية طويلة المدى.

    يشجع الدكتور خرفان دباجة الأشخاص الذين يفكرون في العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) على التحدث مع فرق الرعاية الخاصة بهم حول المخاطر والفوائد المحتملة وأي مخاوف بشأن صحتهم على المدى الطويل. ويوصي أيضًا بالسعي للحصول على تقييم للعلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T) في مركز علاج السرطان الشامل.

    يقول الدكتور: “إذا كنت تعتقد أنك أو شخص عزيز لديك قد تكون مرشحًا لهذا العلاج، فمن الأفضل التواصل مع فريق رعاية لديه خبرة في علاج العديد من مرضى السرطان الذين يتلقون العلاج بالخلايا التائية المستقبلة للمستضدات الخيمرية (CAR-T)”.

    تم نشر هذه المقالة في الأصل على مدونة مركز مايو كلينك الشامل للسرطان.

    ### 

    نبذة عن مايو كلينك
    مايو كلينك هي مؤسسة غير ربحية تلتزم بالابتكار في الممارسات السريرية والتعليم والبحث وتوفير التعاطف والخبرة لكل مَن يحتاج إلى الاستشفاء والرد على استفساراته. لمعرفة المزيد من أخبار مايو كلينك، تفضَّل بزيارة شبكة مايو كلينك الإخبارية.

    [ad_2]

    Mayo Clinic

    Source link

  • Entendendo a terapia celular CAR-T e seus possíveis efeitos colaterais

    Entendendo a terapia celular CAR-T e seus possíveis efeitos colaterais

    [ad_1]

    Newswise — JACKSONVILLE, Flórida — A imunoterapia aproveita o sistema imunológico do corpo para lutar contra o câncer. A terapia de células T com receptor de antígeno quimérico (terapia celular CAR-T) é uma forma de imunoterapia na qual os profissionais de saúde removem as células T de uma pessoa, os glóbulos brancos do sangue conhecidos como linfócitos que estão envolvidos na resposta do sistema imunológico, e fazem a modificação genética para produzir receptores de antígenos quiméricos (CARs). Então, essas células CAR-T são devolvidas à corrente sanguínea do paciente, onde atacam e matam as células cancerígenas.

    “A terapia celular CAR-T está entre as áreas mais promissoras para o tratamento de câncer, com muitas histórias de sucesso ao redor do mundo”, explica o Dr. Mohamed Kharfan Dabaja, hematologista e oncologista da Mayo Clinic. “Ela deu uma esperança para pacientes que tinham opções limitadas.”

    Quem pode receber a terapia celular CAR-T?

    A Administração Federal de Medicamentos dos EUA aprovou a terapia celular CAR-T para tratar os seguintes tipos de câncer do sangue:

    • Precursor de células B, adulto e pediátrico – leucemia linfoblástica aguda (LLA)
    • Linfoma difuso de grandes células B (LDGCB)
    • Linfoma de grandes células B mediastinal primário
    • Linfoma de grandes células B transformado a partir de linfoma folicular
    • Linfoma de células B de alto grau
    • Linfoma de células B agressivo sem especificação
    • Linfoma de células do manto
    • Linfoma folicular
    • Mieloma múltiplo

    As pessoas que receberam esses diagnósticos, cuja doença não respondeu ao tratamento (refratário) ou cuja doença tenha reincido, podem estar aptas para a terapia celular CAR-T. Os pacientes devem passar por uma avaliação completa para determinar se a terapia celular CAR-T é a melhor opção de tratamento.

    Quanto tempo leva para a conclusão da terapia celular CAR-T?

    processo de terapia celular CAR-T é complexo e dura muitas semanas. A maioria das pessoas tem reação às células CAR-T. Elas podem precisar ficar no hospital para receber monitoramento e cuidados.

    “As pessoas que planejam receber a terapia celular CAR-T devem ter a predisposição de permanecer no hospital depois da infusão das células por muitos dias para que a equipe de saúde possa monitorar a resposta à terapia”, explica o Dr. Kharfan Dabaja.

    Quais são os possíveis efeitos colaterais da terapia celular CAR-T?

    Ainda que os efeitos colaterais da terapia CAR-T em geral sejam reversíveis, o Dr. Kharfan Dabaja explica que eles podem incluir:

    • Síndrome de tempestade de citocina (STC): A síndrome de liberação de citocina é um dos efeitos colaterais mais comuns da terapia celular CAR-T e é acionada pela resposta imunológica que ocorre quando as células T modificadas são introduzidas na corrente sanguínea do paciente. Conforme as células T começam a atacar as células cancerígenas, elas liberam um grande número de citocinas, que são proteínas que podem causar uma reação exagerada do sistema imunológico. Isso pode levar à febre, baixa pressão arterial, dor muscular e outros sintomas semelhantes a uma gripe. Em casos graves, a STC pode causar falência de órgãos e pode até ser fatal. A maioria dos sintomas relacionados à STC podem ser gerenciados com medicamentos e monitoramento minucioso.
    • Neurotoxicidade: Alguns pacientes podem sofrer um efeito neurológico conhecido como neurotoxicidade depois de receber a terapia celular CAR-T. O efeito pode ser uma condição potencialmente perigosa na qual a resposta imunológica ao tratamento afeta o sistema nervoso central. Ainda que a causa exata da neurotoxicidade não seja bem compreendida, alguns estudos sugerem que ela esteja parcialmente relacionada com a gravidade da STC. Os sintomas podem incluir confusão, convulsões e dificuldade para falar ou caminhar. Com o monitoramento minucioso, a maioria dos casos de neurotoxicidade é resolvida sem efeitos colaterais de longo prazo.
    • Distúrbios sanguíneos: A terapia celular CAR-T pode resultar em alterações sanguíneas que podem causar anemiatrombocitopenia (baixa contagem de plaquetas) e outros distúrbios sanguíneos. Geralmente, esses efeitos acontecem em um curto período e se resolvem ao longo do tempo, mas eles podem ser mais graves em alguns pacientes.
    • Infecções: As pessoas que recebem terapia celular CAR-T podem ter maior risco de infecções, especialmente durante as primeiras semanas após o tratamento, quando o sistema imunológico trabalha mais do que o normal para lutar contra o câncer. As pessoas com baixa contagem de glóbulos brancos podem ter maior risco de infecções por algum tempo. Elas devem ser monitoradas de perto quanto a sinais de infecção, inclusive febre, calafrios e uma sensação geral de mal-estar.
    • Efeitos colaterais em longo prazo: Dado que a terapia celular CAR-T seja relativamente nova, os profissionais de saúde ainda não sabem qual é o espectro completo dos efeitos colaterais em longo prazo.

    O Dr. Kharfan Dabaja encoraja as pessoas que estão pensando em fazer a terapia celular CAR-T a conversar com as equipes de saúde sobre os possíveis riscos, benefícios e outras preocupações relacionadas com a saúde em longo prazo. Ele também recomenda fazer a avaliação para a terapia celular CAR-T em um centro de câncer abrangente.

    “Se o paciente considera que ele ou algum de seus entes queridos pode ser candidato para a terapia, deve entrar em contato com uma equipe de saúde que tenha experiência no tratamento com a terapia CAR-T em muitos pacientes”, explica o Dr. Kharfan Dabaja.

    Este artigo foi originalmente publicado no blog do Centro de Câncer da Mayo Clinic.

    ### 

    Sobre a Mayo Clinic
    Mayo Clinic é uma organização sem fins lucrativos comprometida com a inovação na prática clínica, educação e pesquisa, fornecendo compaixão, conhecimento e respostas para todos que precisam de cura. Visite a Rede de Notícias da Mayo Clinic para obter outras notícias da Mayo Clinic.

    [ad_2]

    Mayo Clinic

    Source link

  • ¿Quiénes se benefician de la administración de estatinas?

    ¿Quiénes se benefician de la administración de estatinas?

    [ad_1]

    Newswise — ROCHESTER, Minnesota—Si usted corre el riesgo de enfermedad cardíaca, el equipo de atención médica podría utilizar la herramienta de la ecuación de cohorte agrupada para determinar su riesgo a largo plazo y si la administración de estatinas (medicamentos para reducir el colesterol) es una buena opción.

    El Dr. Francisco Lopez-Jimenez, cardiólogo de Mayo Clinic de Rochester, Minnesota, afirma que es importante saber quiénes se benefician más de la administración de estatinas.

    Las estatinas son medicamentos que reducen la cantidad de colesterol que produce el hígado.

    “El colesterol se forma en las placas que se acumulan y crecen en el interior de las arterias, a veces hasta el punto de que esas arterias se obstruyen”, explica el Dr. López-Jiménez.

    Y esa obstrucción puede derivar en una enfermedad cardíaca. Sin embargo, ¿se pueden administrar las estatinas a todas las personas? 

    “Los pacientes que más se beneficiarán de la administración de estatinas serán las personas con antecedentes de ataques cardíacos, accidentes cerebrovasculares y otras afecciones que se sabe que se producen por las placas de colesterol”, afirma.

    La alimentación también desempeña un papel importante. El Dr. Lopez-Jimenez recomienda comer menos carne procesada y más cereales, frutas y verduras.

    “Los cambios de mayor impacto que las personas pueden hacer para reducir el colesterol incluyen consumir menos productos de origen animal que no sean pescado y consumir menos grasas saturadas”, afirma.

    ¿Qué ocurre si el equipo de atención médica recomienda medicamentos además de cambios en el estilo de vida?

    “Tome los medicamentos indicados, verifique las cantidades, asegúrese de que todos esos factores estén bien controlados”, afirma el Dr. Lopez-Jimenez.

    ###

    Información sobre Mayo Clinic

    Mayo Clinic es una organización sin fines de lucro, dedicada a innovar la práctica clínica, la educación y la investigación, así como a ofrecer pericia, compasión y respuestas a todos los que necesitan recobrar la salud. Visite la Red Informativa de Mayo Clinic para leer más noticias sobre Mayo Clinic.

    [ad_2]

    Mayo Clinic

    Source link

  • من الذي يستفيد من تناول أدوية خافِضة للكوليسترول؟

    من الذي يستفيد من تناول أدوية خافِضة للكوليسترول؟

    [ad_1]

    Newswise — مدينة روتشستر، ولاية مينيسوتا—إذا كنت مهددًا بخطرالإصابة بمرض القلب فقد يستخدم فريق الرعاية الصحية أداة معادلة تقييم المخاطر المُشتركة بين الفئات العمرية(PCE)  لتحديد خطر إصابتك على المدى الطويل وما إذا كان تناول أدوية خافِضة للكوليسترول — أدوية خفض الكوليستيرول، خيار مناسب لك أم لا.

    يقول الدكتور فرانسيسكو لوبيز جيمينيز،طبيب القلب لدى مايو كلينك في مدينة روتشستر، ولاية مينيسوتا إنه من المهم أن نفهم من هم الأكثر استفادةً من تناول أدوية خافِضة للكوليسترول.

    أدوية خافِضة للكوليسترول هي أدوية تعمل على خفض مقدار الكوليستيرول الذي يصنعه الكبد.

    يقول الدكتور لوبيز جيمينيز: “الكوليستيرول يتراكم في اللويحات التي تتجمع وتنمو داخل الشرايين، ويصل الأمر أحيانًا إلى انسداد هذه الشرايين.”

    والشرايين المسدودة تؤدي إلى مرض القلب التاجي. ولكن هل تناول أدوية خافِضة للكوليسترول مناسبة للجميع؟ 

    يقول الدكتور جيمينيز: “المرضى الأكثر استفادةً من تناول أدوية خافِضة للكوليسترول هم الأشخاص الذين لديهم تاريخ الإصابة بالنوبات القلبية والسكتات الدماغية وغير ذلك من الحالات المعروف أنها تنشأ عن لويحات الكوليستيرول.”

    كما أن الحمية الغذائية لها دور مهم. يقول الدكتور لوبيز جيمينيز إنه يجب الإقلال من أكل اللحوم المُصنَّعة والإكثار من الحبوب والفاكهة والخضروات.

    ويقول أيضًا: “التغييرات الأكثر تأثيرًا التي يجب على الناس إجراؤها للحد من الكوليستيرول تشمل الإقلال من أكل المُنتجات الحيوانية بخلاف الأسماك والإقلال من تناول الدهون المُشبَّعة.

    وماذا إذا أوصاك فريق الرعاية الصحية بالأدوية إلى جانب تغييرات نمط الحياة؟

    يقول الدكتور لوبيز جيمينيز: “خُذ الأدوية، وافحص مستويات الكوليسترول لديك، وتأكد أن كل العوامل تحت السيطرة.”

    ###

    نبذة عن مايو كلينك

    مايو كلينك هي مؤسسة غير ربحية تلتزم بالابتكار في الممارسات السريرية والتعليم والبحث وتوفير التعاطف والخبرة لكل مَن يحتاج إلى الاستشفاء والرد على استفساراته. لمعرفة المزيد من أخبار مايو كلينك، تفضَّل بزيارة شبكة مايو كلينك الإخبارية.

    [ad_2]

    Mayo Clinic

    Source link

  • Quem se beneficia com a administração de estatinas?

    Quem se beneficia com a administração de estatinas?

    [ad_1]

    Newswise — ROCHESTER, Minnesota—Se você está sob o risco de ter uma doença cardíaca, a equipe de cuidados médicos pode usar a ferramenta de equação de coorte agrupada (PCE) para determinar o seu risco de longo prazo, e se a administração de estatinas (medicamentos para reduzir o colesterol) é uma boa opção.

    O Dr. Francisco Lopez-Jimenez, cardiologista da Mayo Clinic em Rochester, Minnesota, explica que é importante entender quem mais se beneficia com a administração de estatinas.

    As estatinas são medicamentos que reduzem a quantidade de colesterol produzida pelo fígado.

    “O colesterol se forma nas placas que acumulam e crescem dentro das artérias. Às vezes, o acúmulo chega ao ponto de as artérias ficarem bloqueadas”, explica o Dr. Lopez-Jimenez.

    E artérias bloqueadas podem ocasionar o surgimento de doença cardíaca. Mas, as estatinas podem ser usadas por todas as pessoas? 

    “Os pacientes que mais serão beneficiados com a administração de estatinas são aqueles com um histórico de ataques cardíacos, acidentes vasculares cerebrais e outras condições conhecidas decorrentes das placas de colesterol”, ele explica.

    A dieta também tem um papel importante. O Dr. Lopez-Jimenez recomenda consumir menos carne processada e mais grãos, frutas e vegetais.

    “As mudanças mais impactantes que as pessoas podem fazer para reduzir o colesterol incluem consumir menos produtos de origem animal, exceto peixes, e menos gordura saturada”, explica o Dr. Lopez-Jimenez.

    E se a equipe de cuidados médicos recomendar o uso de medicamentos além das mudanças do estilo de vida?

    “Tome os medicamentos, verifique as suas taxas e tenha a certeza de que todos os fatores estarão sob controle”, ele explica.

    ###

    Sobre a Mayo Clinic

    A Mayo Clinic é uma organização sem fins lucrativos comprometida com a inovação na prática clínica, educação e pesquisa, fornecendo compaixão, conhecimento e respostas para todos que precisam de cura. Visite a Rede de Notícias da Mayo Clinic para obter outras notícias da Mayo Clinic.

    [ad_2]

    Mayo Clinic

    Source link

  • Your body knows the difference between good stress and bad stress: Do you?

    Your body knows the difference between good stress and bad stress: Do you?

    [ad_1]

    Newswise — LONDON — It may be surprising to hear, but medically speaking, not all stress is bad. Healthy stress levels help build resilience, says Safia Debar, MBBS, a stress management expert at Mayo Clinic Healthcare in London. In this expert alert, Dr. Debar explains the difference between good and bad stress and how to tell when you are in danger of overload.

    Stress is a physical and psychological reaction to a demand, and that demand can be anything, Dr. Debar says. Stress that is good for us and may even give us a sense of well-being is eustress, the opposite of distress. The same event—for example, getting married—might provoke either one, Dr. Debar says.

    “It’s about the perception of that stress and how your body is actually handling it,” Dr. Debar says. “Chronic stress will impact every organ system in the body: You might feel anxiety, depression and digestive issues, for example.”

    Stress prompts a cascade of reactions within the mind and body as you mount a stress response, Dr. Debar says. Under normal stress, a person starts at a baseline of relaxation, encounters a stressor, the stress response begins, rises to a peak, and then comes back down to baseline.

    Among the physical changes that may occur when you perceive a threat:

    • The sympathetic nervous system and production of the primary stress hormone, cortisol, activate.
    • Thinking becomes negative as you experience or anticipate something bad. Attention becomes hyperfocused on what is happening.
    • The heart, lungs and muscles prepare for you to fight or run. There is increased heart rate, blood pressure and breathing rate as the body needs to deliver more oxygen to cells. Muscles tense.
    • The digestive and reproductive systems aren’t needed, so their activities slow.
    • The immune system turns its attention from fighting microscopic invaders such as viruses or cancer cells and goes into an inflammatory mode, increasing its production of proteins called cytokines that adjust this process.  

    When someone realizes the threat has passed, the body begins to repair itself from this response and “tidy up”. It shifts to a repair, renew and growth state as the stress response is mopped up. Physically, breathing and heart rate slow down, blood pressure normalizes, you take more expansive breaths, muscular tension eases, the digestive and reproductive systems resume normal activity, and you may begin to connect with others to recount the threat you just experienced, Dr. Debar says.

    “If you go up in stress and then come back down, you have completed our cycle. There’s no wear and tear, there’s no damage,” Dr. Debar says. “In fact, it’s probably good for you because it leads to greater resilience. If you’ve ever overcome a stressful event in life, processed it fully and completed that cycle, then the next similar experience you have, you think, `Oh no, but I can do it.’”

    However, when someone is repeatedly under too much stress, the ability to go back to baseline slowly starts to wane, Dr. Debar says.

    “You can go up in stress and stay there, having a prolonged response. This is when you’re hypervigilant: You’re wired but tired, you’re anxious,” Dr. Debar says. “Or, life has thrown at you so many stressors, that you respond inadequately. It is the lack of recovery rather than the actual stressor itself that is critical. After a while, you may just numb out and show no response.”

    Sometimes people think it would be good to show no response, Dr. Debar adds, but internally the stress response and its cascade of internal activities are still happening. They are just hidden.

    There are several signs that you may be in danger of stress overload and it is time to address it, Dr. Debar says:

    • If stress feels unremitting and constant.
    • If stress feels uncontrollable and you’re unable to relax or feel like you’re on autopilot.
    • If you have problems regulating emotions.
    • If you start hiding from life and/or people.
    • You’re experiencing physical symptoms such as headaches, chest pain, stomach upsets, problems sleeping, or getting sick more often.

    “Think about how your body handles stress, and how you handle it emotionally, physically and in your relationships,” Dr. Debar says. “What do you do, what do you not do.”

    Chronic stress can have long-term health effects. People who feel ongoing physical symptoms or find that lifestyle changes do not seem to help should consult with their health care team, Dr. Debar says.

    ###

    About Mayo Clinic Healthcare
    Mayo Clinic Healthcare, located in London, is a wholly owned subsidiary of Mayo Clinic, a not-for-profit academic medical center. Mayo Clinic is ranked No. 1 by U.S. News & World Report in more specialties than any other hospital for a reason: quality of care. Mayo Clinic Healthcare is the U.K.’s front door to that unparalleled experience. Visit Mayo Clinic Healthcare for more information.

    [ad_2]

    Mayo Clinic

    Source link

  • Inovação em IA da Mayo Clinic traz expectativa para a detecção precoce de câncer de pâncreas

    Inovação em IA da Mayo Clinic traz expectativa para a detecção precoce de câncer de pâncreas

    [ad_1]

    Newswise — ROCHESTER, Minnesota — Existe uma estimativa de que o câncer de pâncreas se tornará a segunda causa principal de morte provocada por câncer até 2030. Com um prognóstico desolador, aproximadamente 70 por cento dos pacientes morrem no primeiro ano de diagnóstico. Infelizmente, 40 por cento dos cânceres de pâncreas não são detectados nos exames de tomografia computadorizada (TC), então, eles avançam para um estágio incurável.

    Esse cenário cria uma barreira crítica, a “última fronteira” para os esforços de detecção precoce, e para maioria dos pacientes, inclusive aqueles com alto risco que passam pela triagem ativa, o exame de imagem detecta o câncer em um estágio onde a cura é improvável. Isso faz com que o exame de imagem se torne a última fronteira na busca da detecção precoce do câncer.

    Em um avanço recente, os pesquisadores do Centro de Câncer da Mayo Clinic usaram o conjunto de dados de exames de imagens mais extenso do mundo para construir um modelo de inteligência artificial (IA) versátil que demonstrou o potencial de detecção autônoma do câncer de pâncreas em tomografias computadorizadas onde a intervenção cirúrgica ainda pode gerar a cura.

    “Aqui é onde o estudo surge como um farol de otimismo”, explica Ajit H. Goenka, médico radiologista na Mayo Clinic, pesquisador principal e autor correspondente. “Ele soluciona o desafio da última fronteira ao detectar o câncer em um estágio no qual ele ainda está além do escopo de especialistas.”

    O grupo desenvolveu um modelo de IA altamente preciso, treinado no maior e mais diverso conjunto de dados de tomografia computadorizada, com mais de 3 mil pacientes, para a detecção de câncer completamente automatizada, inclusive os tumores pequenos e outros de difícil detecção. Publicado na Gastroenterology, a revista da Associação Americana de Gastroenterologia, o estudo não só se baseia no trabalho recente do grupo sobre modelos de detecção precoce baseados em radiômica, como também destaca a posição da Mayo Clinic como um farol de inovação para as soluções de cuidados em saúde com o uso de IA.

    O mais importante é que o modelo poderia detectar o câncer visualmente imperceptível a partir dos pâncreas com aparências normais em exames de imagens pré-diagnósticas de tomografia computadorizada, ou seja, as imagens obtidas em 3 a 36 meses antes do diagnóstico clínico, substancialmente precoces, em média 438 dias, antes do diagnóstico clínico.

    “Essas descobertas sugerem que a IA tem o potencial de detectar cânceres ocultos em pessoas assintomáticas, permitindo o tratamento cirúrgico em um estágio no qual a cura ainda é possível”, explica o Dr. Goenka. 

    Finalmente, o modelo permaneceu confiável e preciso entre os diversos grupos e variações de pacientes no equipamento de varredura e técnicas de exame de imagem. Essa resiliência é fundamental para a utilidade do modelo em um amplo conjunto de cenários médicos no mundo real.

    Ao lidar com um interesse principal no cenário de cuidados em saúde com o uso de IA, a equipe também desconstruiu um processo de tomada de decisão da IA para garantir transparência e reconhecer que a confiança e controle de qualidade são essenciais para a aceitação clínica mais ampla da IA.

    “Devemos esse progresso aos esforços engenhosos da Estrutura para Tecnologia de Software em IA, equipe liderada pelo Dr. Panagiotis Korfiatis e complementada pela nossa equipe de bolsistas de pesquisa e analistas de ciência de dados excepcionalmente brilhantes”, explica o Dr. Goenka. “Eles dedicaram meses de preparação meticulosa para o nosso envio inicial e investiram um esforço significativo para responder astutamente às consultas incisivas do painel de analistas internacionais.”

    “Estamos apenas no começo, mas estamos preparados para lidar com os desafios relativos à detecção precoce de câncer e potencializar as capacidades da IA e do exame de imagem molecular de próxima geração em consonância com os biomarcadores moleculares”, acrescenta o Dr. Goenka.

    A Mayo Clinic já iniciou as etapas para a validação clínica e os modelos estão sendo submetidos a processos regulatórios. Com o apoio do Centro de Câncer da Mayo Clinic, a equipe está pronta para realizar ensaios de triagem prospectivos financiados por benfeitores. As descobertas a partir desses ensaios refinarão e reforçarão a efetividade prática de suas abordagens inovadoras.

    Seus esforços interdisciplinares envolvem coautores especialistas em radiologia (Dra. Garima Suman, Dr. Nandakumar Patnam Gopal Chetty, bacharel em medicina e cirurgia, Dra. Kamaxi H. Trivedi, bacharel em medicina e cirurgia, Dra. Aashna M. Karbhari, bacharel em medicina e cirurgia, Dr. Sovanlal Mukherjee, Dr. Cole J. Cook, mestre em ciências, Dr. Jason R. Klug, Dr. Naveen Rajamohan, Dra. Hala A. Khasawneh, Dr. Joel G. FletcherDra. Candice W. Bolan e Kumar Sandrasegaran, bacharel em medicina e cirurgia), cirurgia (Dr. Mark J. Truty, mestre em ciências) e gastroenterologia (Dr. Shounak Majumder e Dr. Suresh T. Chari).

    A pesquisa relatada neste comunicado de imprensa recebeu apoio do Instituto Nacional do Câncer dos Institutos Nacionais de Saúde com os números de subvenção R01CA272628 e R01CA256969, assim como da Fundação de Caridade Centene e Programa de Pesquisa para o Câncer de Pâncreas Campeões do Otimismo da Fundação Funk Zitiello. O conteúdo é de responsabilidade exclusiva dos autores e não representa necessariamente as opiniões oficiais dos Institutos Nacionais de Saúde.

    ###

    Sobre a Mayo Clinic
    Mayo Clinic é uma organização sem fins lucrativos comprometida com a inovação na prática clínica, educação e pesquisa, fornecendo compaixão, conhecimento e respostas para todos que precisam de cura. Visite a Rede de Notícias da Mayo Clinic para obter outras notícias da Mayo Clinic.

    [ad_2]

    Mayo Clinic

    Source link

  • تزيد الخلايا المناعية المسنة من نمو ورم الرئة تبعًا لورقة بحثية

    تزيد الخلايا المناعية المسنة من نمو ورم الرئة تبعًا لورقة بحثية

    [ad_1]

    Newswise — مدينة روتشستر، ولاية مينيسوتا — البلعميات هي إحدى أنواع خلايا الدم البيضاء، وهي جزء من خط الدفاع الأول للجسم ضد العدوى. بالإضافة إلى دورها في قتل الكائنات الدقيقة الضارة، يمكن للبلعميات بدء استجابة الجسم ضد الأورام. على الرغم من ذلك، فالبلعميات -مثل كل الخلايا الأخرى- تتقدم في العمر، وربما تدخل في مرحلة الشيخوخة. قد يرتبط هذا بتقدم عمر الإنسان، أو إصابته بالأمراض، أو بمختلف المشكلات الفسيولوجية.

    عندما تصبح البلعميات خلايا مسنة، تتوقف عن التكاثر، إلا أنها لا تموت، ولا يتم التخلص منها دائمًا. لذا تتراكم البلعميات المسنة في بعض الأنسجة وتفرز بعض الجزيئات الضارة. لهذا يطلق على الخلايا المسنة اسم “خلايا الزومبي”. وحتى الآن، لم نستطع التوصل إلى سبب تحول الخلايا السليمة إلى خلايا مسنة.

    في هذا البحث الجديد والذي نُشر في مجلة Cancer Cell البحثية، اكتشف الباحثون أن الخلايا البلعمية المسنة لا تتراكم فقط في الرئة، بل وتعزز من نمو ورم الرئة.

    وضح د. دارِن بيكر أن “البيولوجي المتخصص في الخلايا المسنة في Mayo Clinic وكبير المؤلفين” من الناحية النظرية، لم نتوقع وجود احتمالية لأن تتحول البلعميات لخلايا مسنة تتسبب في نمو الورم. “لذا يقربنا هذا البحث خطوة من فهم كيفية تكون الأورام على المستوى الخلوي.”

    اكتشف د. بيكر وزملاؤه أن البلعميات المسنة قد تمنع الجهاز المناعي من الاستجابة لمنع النمو الشاذ للخلايا. وبالتالي يؤدي هذا لتكون ورم.

    “ووضح د. لويس بريتو، الباحث الرئيسي، وزميل أبحاث ما بعد الدكتوراه، وخريج كلية Mayo Clinic للدراسات العليا للعلوم الطبية الحيوية. “استطعنا من خلال التجارب والتحليلات المختلفة أن نفرّق بين البلعميات المسنة وغيرها من البلعميات الطبيعية. ووجدنا أنه إنه استطعنا التخلص من البلعميات المسنة بأساليب جينية أو دوائية، فيمكننا تأخير عملية تكوٌن الورم.

    استنتج الباحثون أن الخلايا محتملة التسرطن تتواصل مع الخلايا المحيطة بها بما في ذلك البلعميات. وتحفز الخلايا محتملة التسرطن البلعميات لتتحول لخلايا مسنة. بعدها، تساهم الخلايا المسنة في تغيير المنطقة المحيطة لتعزيز نمو الورم.

    في البداية اعتقد الباحثون أن التخلص من الخلايا المسنة سيؤدي إلى زيادة الأورام الغُدّية في الرئة، وهو نوع الورم الذي كانوا يدرسونه. ولكن أظهرت نتائج التجارب الأولية خلاف ذلك.

    وضح د. بريتو “كان الأمر محفِّزًا، فكلما قمنا بتجربة كانت النتائج عكس توقعنا تمامًا.” “إن أزلنا مثبطات الأورام المسنة فمن المتوقع أن تزيد نسبة الأورام. ولكن النتائج أظهرت العكس. فبعد إزالة مثبطات الأورام المسنة، قلت نسبة الأورام.”

    عمل الباحثون مع المؤلف المشارك د. هو لي، الباحث في الطب الفردي في Mayo Clinic، وأجروا تسلسل الحمض الننوي الريبوزي أحادي الخلية في معمله. ساهم هذا البحث في تحديد البلعميات الرئوية كخلية رئيسية تعزز نمو الأورام. والآن، يعتقد الباحثون أن البلعميات تستجيب لإشارات الخلايا محتملة التسرطن مع بدء تكون الورم.

    يقول د. بيكر “أعدنا التفكير في فرضياتنا الأولية، فقد تعملنا الكثير عما يمكن أن تفعله الخلايا. بعدها اتضح لنا كيف يمكن للبلعميات المسنة أن تؤثر على الخلايا الأخرى وعلى البيئة وعلى جهاز المناعة.”

    دُعم هذا البحث من قبل مركز بول ف. جلين لعلم أبحاث الشيخوخة البيولوجي التابع لـ Mayo Clinic وكلية Mayo Clinic للدراسات العليا للعلوم الطبية الحيوية.

    تم نشر ورقة بحثية تكميلية في مجلة Cancer Cell من قبل الباحثين في المملكة المتحدة.

    للحصول على القائمة الكاملة للمؤلفين والإفصاحات والتمويل، راجع الورقة البحثية.

    لمزيد من المعلومات، يرجى زيارة ديسكافريز إيدج.

    ### 

    نبذة عن مايو كلينك
    مايو كلينك هي مؤسسة غير ربحية تلتزم بالابتكار في الممارسات السريرية والتعليم والبحث وتوفير التعاطف والخبرة لكل مَن يحتاج إلى الاستشفاء والرد على استفساراته. لمعرفة المزيد من أخبار مايو كلينك، تفضَّل بزيارة شبكة مايو كلينك الإخبارية.  

    [ad_2]

    Mayo Clinic

    Source link

  • Por qué las personas adultas de la comunidad LGBTQ+ deben prestar atención a la salud cardíaca

    Por qué las personas adultas de la comunidad LGBTQ+ deben prestar atención a la salud cardíaca

    [ad_1]

    Newswise — ROCHESTER, Minnesota — En estudios recientes se ha observado una tendencia preocupante en la salud cardiovascular de las personas adultas de la comunidad LGBTQ+. Tienen una peor salud cardíaca en comparación con las personas cisgénero heterosexuales. Las personas LGBTQ+ también tienden a tener una mayor prevalencia de factores de riesgo de enfermedad cardiovascular.

    La Dra. Rekha Mankad, cardióloga de Mayo Clinic, explica lo que puede aumentar el riesgo de enfermedad cardiovascular en las personas adultas LGBTQ+ y lo que se puede hacer para disminuirlo.

    “La comunidad LGBTQ+ es un grupo de personas marginalizado”, dice la Dra. Mankad. “Uno de los primeros problemas es que quizás no acudan a realizarse exámenes médicos periódicos”.

    Cuando se trata de prevenir enfermedades cardiovasculares, es fundamental conocer los factores de riesgo.

    Estos son los factores de riesgo comunes de las enfermedades cardíacas:

    • Presión arterial alta
    • Colesterol alto
    • Consumo de tabaco
    • Diabetes
    • Falta de actividad física
    • Obesidad

    “Son cosas de las que hablamos con todos, pero se debe consultar con un proveedor de atención médica para hablar acerca de esos factores de riesgo”, explica la Dra. Mankad.

    Alrededor de la mitad de las personas LGBTQ+ dicen que han sufrido discriminación en el entorno sanitario, lo cual es un factor que hace que sea menos probable que vean a un médico en comparación con las personas cisgénero heterosexuales.

    “Si a una persona le preocupa ir al médico, seguramente no va a hablar de los aspectos que la ponen en riesgo de presentar enfermedades cardíacas”, aclara la doctora.

    La Dra. Mankad dice que otro factor puede ser la presencia de factores estresantes particulares de los grupos marginalizados.

    “Existen tensiones interpersonales, tales como la autoestigmatización y cuestiones relacionadas con el ocultamiento. Además, lidian con problemas como los prejuicios que han sufrido y, posiblemente, la violencia”, aclara.

    El estrés puede derivar en otros problemas

    “Si una persona se expone a mayor estrés, es más probable que presente ansiedad o depresión”, dice la Dra. Mankad. “Además, es menos probable que salga y haga ejercicio porque siente incomodidad en un vestidor o vestuario. Estos son algunos de los muchos factores que luego pueden generar una mayor probabilidad de desarrollar esos factores de riesgo de enfermedades cardíacas”.

    Ante estas circunstancias, es fundamental que las personas de la comunidad LGBTQ+ sean proactivas con respecto a su salud cardíaca.

    “Les diría a las personas de la comunidad que no duden en ver a un proveedor de atención médica y que le hablen con honestidad”, agrega la Dra. Mankad. “Háganle saber sus preocupaciones en relación con la salud en general, en especial la salud cardiovascular, y elaboren un plan sobre lo que pueden hacer para proteger el corazón a largo plazo”.

    ###

    Información sobre Mayo Clinic
    Mayo Clinic es una organización sin fines de lucro, dedicada a innovar la práctica clínica, la educación y la investigación, así como a ofrecer pericia, compasión y respuestas a todos los que necesitan recobrar la salud. Visite la Red Informativa de Mayo Clinic para leer más noticias sobre Mayo Clinic.

    [ad_2]

    Mayo Clinic

    Source link

  • Zero Lead Is an Impossible Ask for American Parents

    Zero Lead Is an Impossible Ask for American Parents

    [ad_1]

    Over the past eight months, I’ve spent a mind-boggling amount of time and money trying to keep an invisible poison at bay. It started at my daughter’s 12-month checkup, when her pediatrician told me she had a concerning amount of lead in her blood. The pediatrician explained that, at high levels, lead can irreversibly damage children’s nervous system, brain, and other organs, and that, at lower levels, it’s associated with learning disabilities, behavior problems, and other developmental delays. On the drive home, I looked at my baby in her car seat and cried.

    The pediatrician told me that we needed to get my daughter’s lead level down. But when I began to try to find out where it was coming from, I learned that lead can be found in any number of places: baby food, house paint, breast milk, toys, cumin powder. And it’s potent. A small amount of lead dust—equal to one sweetener packet—would make an entire football field “hazardous” by the EPA’s standards.

    My husband and I spent nearly $12,000 removing highly contaminated soil from our backyard, replacing old windows, and sealing an old claw-foot bathtub. We mopped the floors at night, obsessively washed our daughter’s hands, and made sure to feed her plenty of iron, calcium, and vitamin C, which are thought to help limit the body’s absorption of lead. Four months later, when we went back to the pediatrician, her lead levels had sunk from 3.9 micrograms per deciliter of blood to 2.2 mcg/dL. That was better, but still far from zero. And according to the CDC, the World Health Organization, and the Mayo Clinic, zero is the only safe amount of lead.

    We’re one of thousands of families who have gone through that ordeal this year. At least 300,000 American children have blood lead levels above 3.5 mcg/dL, the CDC’s so-called reference value. But parents are largely left on their own to get lead out of their kids’ lives. Families who can afford an abundance of caution can sink tens of thousands of dollars into the project. And they still might never hit zero.

    When Suz Garrett learned that her 1-year-old son, Orrin, had four micrograms of lead in every deciliter of his blood, she and her husband waited for guidance from their doctor or the county health department, but none came. So they sent Orrin to stay with family while they repainted their 19th-century Richmond, Virginia, house and covered the open soil with mulch. Band-Aids like these are cost-effective, but every time you pry open an old window, or your dog tracks in dirt from the neighbors’ yard, invisible specks of lead dust can build up again.

    For nearly a year, the Garretts cleaned religiously. Orrin’s blood levels are still detectable—currently, he’s at 2.1 mcg/dL. Garrett and her husband are fed up. In a few months they’re moving to a new house, one they took out a $200,000 construction loan to renovate. “We ended up gutting it so we would know there’s no lead paint,” Garrett said.

    A few years ago, children like Orrin Garrett and my daughter wouldn’t have been a cause for concern. Until 2012, children were identified as having a blood lead “level of concern” at 10 mcg/dL or more. But for the past decade, the CDC has used a reference value to identify children who have more lead in their blood than most others. The reference number is based on statistics, not health outcomes. When most children tested below 5 mcg/dL, the reference level was five. Today, it is 3.5.

    The reference level has trended down along with lead exposure, which has dropped by 95 percent since the 1970s thanks to policies that removed lead from gasoline, paint, plumbing, and food. But confusion and concern about what classifies as lead poisoning has risen.

    Scientists and public-health officials still can’t say exactly how low lead exposure needs to be to prevent damage for any individual child. When Kim Dietrich, an epidemiologist and a developmental neuropsychologist, started his career in the ’70s, the general consensus was that levels above 40 to 60 micrograms took a significant toll on the developing brain. But work by Dietrich and others showed that harm can be caused at much lower levels. In the early 2000s, pooled data from seven large studies from around the world, including one Dietrich conducted in Cincinnati, showed that an increase in children’s blood-lead concentration from 2.4 to just 10 mcg/dL corresponded with a four-point drop in their IQ. That’s a scary prospect. But, Dietrich told me, “it’s very important not to confuse findings from these large population-level studies with individual impacts.”

    Discerning the effect of low lead levels—below about 10 mcg/dL—on cognitive health is an extremely complicated issue. “If you’ve got a blood alcohol content of 0.2, you’re likely to be horribly dangerous behind the wheel no matter who you are. Lead is a little bit different. Your child’s two might be worse than my child’s 10,” Gabriel Filippelli, a biogeochemist who studies lead exposure in urban environments, told me. Part of the variation in outcomes could be the result of factors we still don’t understand, like a child’s genetic makeup.

    Policing low levels of lead exposure in children costs parents both financially and emotionally. Mary Jean Brown, the former chief of the CDC’s Healthy Homes and Lead Poisoning Prevention Program, told me that concerned parents should be careful not to create a self-fulfilling prophecy. “Most children will not exhibit any symptoms when they have blood levels of 5 or 10 micrograms per deciliter,” she told me. But “if the mother or someone else says, ‘Johnny’s not like everybody else,’ pretty soon, Johnny isn’t like everybody else.”

    This type of anxiety is familiar to Tanisha Bowman, a health-care worker in Pittsburgh who has spent nearly three years trying to lower her daughter’s blood lead levels. They initially peaked at 20 mcg/dL, and have ranged from two to six over the past year. “There was never anything wrong with her. She was always measuring four to six months ahead,” Bowman said. But it was impossible not to read scary headlines about lead and assume they applied to her daughter. When she had tantrums around the age of 2, Bowman started wondering if she had ADHD, which is sometimes associated with lead exposure. “I will never know what impact, if any, this had on her. And nobody will ever be able to tell me,” she said. (Bowman’s daughter has had no diagnosis related to lead.)

    In the absence of a specific, outcome-based number to help parents decide when to worry, a mantra has emerged among doctors, reporters, and health institutions: There is no safe level of lead. Filippelli said that he’s used the catchphrase, but it’s a bit misleading. “There is no valid research source to support the ‘No amount of lead exposure is safe’ idea, beyond that fact that to avoid the potential of harm, you should avoid exposure,” he explained in an email.

    As well intentioned as the guidance might be, avoiding all exposure is an impossible quest. Tricia Gasek, a mother of three who lives in New Jersey, tried desperately to locate the source of lead in her children’s blood. She spent $1,000 hiring a “lead detective” to test her home with an XRF device and getting consultations with experts, plus another $600 replacing leaded lights on the front door. Ultimately, she learned that she also had elevated levels and concluded that the lead in her son’s blood was coming from her breast milk—possibly, her doctors thought, from exposure she had as a child. The process was exhausting. “It’s just crazy. Why am I the one figuring all this out?” she says.

    Parents simply can’t get to zero without help. Lead is invisible and pervasive. Although the Flint, Michigan, water crisis and recent product recalls have raised awareness about lead leaching from corroding pipes and hiding inside baby food, the biggest sources of exposure for children are the spaces where they live and play: inside houses and apartments with old, degrading paint and yards with contaminated soil. For many, there is no easy escape. Lead contamination is most common in low-income neighborhoods, which means Black and Hispanic kids are disproportionately affected.

    Many local health departments, including the one where I live, offer home visits to help identify sources of lead, but in many cases only when levels are above 10 mcg/dL. So the majority of children with elevated lead levels receive little or no assistance at all, and families have to play detective, social worker, and home remodeler all at once.

    This is paradoxical, because the problem of low-level lead exposure cannot be solved by focusing on one child or one home at a time. My family’s efforts helped lower our daughter’s lead levels slightly, but they did nothing to address the more widespread problem of lead in our neighborhood, to which she and all the other children nearby are still exposed. Instead of having every lead-exposed family play whack-a-mole in their own home, Filippelli says that if he were appointed czar of lead, he would do a national analysis of high-risk neighborhoods and households, perform targeted testing to confirm hazards, and remediate at scale. There would have to be coordination between the Department of Housing and Urban Development and the Environmental Protection Agency, and such programs could cost up to $1 trillion and take a decade. But, he says, we could significantly reduce lead exposure across the board. The trickle-down effects of half a million children becoming smarter, healthier adults would reach everyone, even if we can’t say exactly how much smarter or healthier they’d be.

    For now, my family is still navigating this maze on our own. I’m trying to think of low-level lead exposure as a risk factor—like air pollution and forever chemicals—instead of a diagnosis. Meanwhile, my daughter is doing just fine. As a family, we’ll continue to avoid what lead we can; we’ve decided to spend a whopping $25,000 to repaint the chipping exterior of our house. But we’re still going to let our kid play at the park and climb the walls. After all, there’s no stopping her.

    [ad_2]

    Lauren Silverman

    Source link

  • Tecnologia Inovadora Trata Cânceres De Cabeça E PescoçO

    Tecnologia Inovadora Trata Cânceres De Cabeça E PescoçO

    [ad_1]

    Newswise — JACKSONVILLE, Flórida — No mundo todo, o papilomavírus humano (HPV) é responsável por grande parte dos cânceres de cabeça e pescoço, de acordo com a Organização Mundial da Saúde. Nos Estados Unidos, o HPV está associado a cerca de 70 por cento dos cânceres de garganta e boca. E mais de 70 por cento desses cânceres são diagnosticados em homens, de acordo com os Centros de Controle e Prevenção de Doenças (Centers for Disease Control and Prevention, CDC) dos EUA.

    O tratamento dos cânceres de garganta e boca, também chamados de cânceres orofaríngeos ou cânceres de cabeça e pescoço, depende da localização e do estágio da doença, além de outros fatores.

    Dr. Phillip Pirgousis, cirurgião de cabeça e pescoço da Mayo Clinic na Flórida, diz que atualmente os pacientes contam com tratamentos cirúrgicos mais seguros e menos invasivos para cânceres de cabeça e pescoço, disponíveis graças a uma tecnologia inovadora.

    Casos de câncer relacionados ao HPV estão aumentando em duas áreas específicas da garganta.

    “Nas amígdalas na parte posterior da garganta e no tecido do linfonodo na parte posterior da língua”, relata o Dr. Pirgousis.

    Cânceres nesses dois locais podem ser um desafio.

    “Muitos dos desafios costumam estar relacionados à localização do tumor primário, porque é difícil acessar a garganta e a área da laringe ou caixa de voz”, explica ele.

    Diante desse cenário desafiador é que a inovação com robótica possibilita melhor visualização do tumor, melhor iluminação e melhores resultados em termos de completa remoção do tumor.

    “Estamos falando aqui de grandes cirurgias abertas comparadas com cirurgias minimamente invasivas, nas quais conseguimos acessar esses locais difíceis fazendo incisões faciais”, complementa ele.

    “E causando menor impacto na respiração, na fala, na deglutição e na comunicação. O robô cirúrgico melhorou nossa capacidade não só de remover completamente os tumores, mas de realizar essa remoção com segurança”, avalia o Dr. Pirgousis.

    Cirurgia robótica transoral

    cirurgia robótica transoral é uma técnica cirúrgica minimamente invasiva que usa um sistema de computador para ajudar a guiar as ferramentas cirúrgicas pela boca. Os braços robóticos são controlados por um cirurgião que opera um console e guia os braços para realizar a cirurgia. O console proporciona ao cirurgião uma visão 3D ampliada de alta definição do local da cirurgia. O cirurgião lidera outros integrantes da equipe que auxiliam durante a cirurgia.

    Opções de tratamento para cânceres de cabeça e pescoço

    tratamento é baseado em muitos fatores, incluindo localização, estágio do câncer, tipo de células envolvidas, a saúde geral e preferências pessoais dos pacientes. O paciente pode fazer receber apenas um tipo de tratamento, ou pode se submeter a uma combinação de tratamentos contra o câncer. A equipe médica trabalhará com o paciente para determinar o melhor plano de tratamento para o caso.

    O tratamento pode incluir:

    • Radioterapia
    • Cirurgia para remover o câncer que não se espalhou para outras áreas
    • Cirurgia para remover parte da garganta, caixa vocal ou nódulos linfáticos
    • Quimioterapia
    • Terapia medicamentosa
    • Imunoterapia

    ###

    Sobre a Mayo Clinic
    Mayo Clinic é uma organização sem fins lucrativos comprometida com a inovação na prática clínica, educação e pesquisa, fornecendo compaixão, conhecimento e respostas para todos que precisam de cura. Visite a Rede de Notícias da Mayo Clinic para obter outras notícias da Mayo Clinic.

    [ad_2]

    Mayo Clinic

    Source link